Other Briefings
China Clarifies Medical Device Classification for Brain-Computer Interfaces: A Guide for Foreign Investors
NMPA’s new guideline sorts BCI devices into concrete risk classes and registration pathways, turning what used to be a regulatory guessing game into a roadmap foreign investors can actually plan around. Find out which devices get the fast-track Class II route, which face the full Class III gauntlet, and what it all means for your China market entry strategy.
China’s Medical Device Industry – Why Beijing is the Place to Invest
Beijing is fast becoming China’s leading hub for innovative medical devices, backed by dedicated industrial parks, policy incentives, and world-class research infrastructure. We look at where the opportunities lie for foreign companies and how to position for market entry.
China Manufacturing Tracker 2026
Our tracker provides continuous updates on key economic and growth indicators in China’s manufacturing industry. The data for May 2026 has now been updated.
China’s Maternity and Baby Market (Part II): Key Segments and Opportunities for Foreign Brands
China’s maternity and baby market offers clear opportunities for foreign brands. But the market is competitive, regulated, and highly segmented. Part II maps the key product and service segments, the real challenges foreign entrants face, and where the strongest opportunities lie.
China’s Maternity and Baby Market (Part I): Demographics, Policy, and Market Structure
China’s maternity and baby market is shifting from volume to value. In Part I of this two-part series, we cover the demographics, policy landscape, and market structure foreign brands and investors need to understand before entering.
China’s Nuclear Fusion Sector: What the 15th FYP Means for Businesses and Investors
China’s nuclear fusion sector is rapidly taking shape as an emerging industrial market, with increasing investment and activity across reactor supply chains, advanced materials, and engineering systems. While commercial power generation remains a long-term goal for the 2030s–2040s, near-term business opportunities are already developing in component manufacturing, testing infrastructure, and technology partnerships.
China’s Agentic AI Boom: What the OpenClaw Surge Reveals
China’s rapid uptake of OpenClaw highlights the country’s transition from experimental generative AI toward agentic, task‑executing systems. The shift is reshaping China’s AI value chain, with implications for cloud services, enterprise automation, and foreign market entry strategies.
China’s Brain-Computer Interface Industry – Tapping into the Future of Human-Machine Integration
China is investing heavily in brain-computer interface technology, opening up vast new frontiers in healthcare, rehabilitation, and entertainment.
